BRIEF published on 11/15/2024 at 08:05, 8 days 1 hour ago Aquis Stock Exchange: Securities Withdrawal Aquis Stock Exchange Market Update Securities Withdrawal Substrate AI Share Delisting
PRESS RELEASE published on 11/15/2024 at 08:00, 8 days 1 hour ago Aquis Stock Exchange: Withdrawal from Trading Substrate Artificial Intelligence S.A. ordinary and preference shares to be withdrawn from Aquis Stock Exchange Growth Market Ordinary Shares Aquis Stock Exchange Preference Shares Withdrawal Substrate Artificial Intelligence S.A.
BRIEF published on 11/01/2024 at 08:05, 22 days 1 hour ago Aquis Stock Exchange Suspends Helium Ventures PLC Trading Regulation Aquis Growth Market Annual Accounts Trading Suspension Helium Ventures
PRESS RELEASE published on 11/01/2024 at 08:00, 22 days 1 hour ago Aquis Stock Exchange: Suspension of Trading Aquis Stock Exchange suspends trading of Helium Ventures PLC Ordinary Shares for not submitting annual audited accounts as of 01-Nov-2024 Trading Aquis Stock Exchange Suspension Helium Ventures PLC Annual Audited Accounts
BRIEF published on 10/31/2024 at 08:05, 23 days 1 hour ago Aquis Stock Exchange: Quantum Exponential Group Delisting Aquis Stock Exchange Growth Market Delisting Trading Withdrawal Quantum Exponential Group
PRESS RELEASE published on 10/31/2024 at 08:00, 23 days 1 hour ago Aquis Stock Exchange: Withdrawal from Trading Quantum Exponential Group plc's Ordinary Shares (Symbol: QBIT, ISIN: GB00BLR8M858) to be withdrawn from trading on Aquis Stock Exchange Growth Market Aquis Stock Exchange Withdrawal Quantum Exponential Group Plc QBIT GB00BLR8M858
BRIEF published on 10/10/2024 at 08:05, 1 month 13 days ago Aquis Stock Exchange: Trading Suspension Notice Regulatory Compliance Aquis Stock Exchange Trading Suspension Mydecine Innovations Exchange Fees
PRESS RELEASE published on 10/10/2024 at 08:00, 1 month 13 days ago Aquis Stock Exchange: Suspension of Trading Aquis Stock Exchange suspends trading of Mydecine Innovations Group Inc Ordinary Shares (Symbol: MYIG) for failure to pay exchange fees as per Rule 3.10 of Rulebook Trading Aquis Stock Exchange Suspension Exchange Fees Mydecine Innovations Group Inc
BRIEF published on 10/01/2024 at 08:05, 1 month 22 days ago Aquis Stock Exchange: Suspension of Trading Trading Regulation Aquis Stock Exchange Suspension Vulcan Industries
PRESS RELEASE published on 10/01/2024 at 08:00, 1 month 22 days ago Aquis Stock Exchange: Suspension of Trading Aquis Stock Exchange suspends trading of Vulcan Industries plc shares due to failure to publish annual audited accounts. Announcement made on 01-Oct-2024 Trading Aquis Stock Exchange Annual Accounts Suspension Vulcan Industries Plc
Published on 11/22/2024 at 23:55, 9 hours 27 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 52 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 17 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 52 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 29 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 27 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 22 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 14 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
